Directory

>

Kevin Webster

Kevin Webster

Chief Science Officer | Frontier Medicines

Boston, Massachusetts, United States

View contact details (it's free)

Kevin Webster

Summary

Kevin Webster is a highly accomplished Chief Scientific Officer at Frontier Medicines, where he leads innovative research in the biopharmaceutical sector, particularly focused on cancer treatment. With a robust academic foundation, including a PhD from Yale University in Molecular Biophysics and Biochemistry, he has dedicated over three decades to advancing drug discovery and development. His extensive experience spans various leadership roles across notable companies like AstraZeneca and Bristol Myers Squibb, where he has significantly contributed to oncology research. Kevin's expertise encompasses a wide range of scientific disciplines, including biochemistry, bioinformatics, and translational medicine. He is passionate about leveraging cutting-edge technologies to create breakthrough therapies that can transform patient outcomes. Beyond his technical acumen, he is recognized for his strategic vision and ability to foster collaborative partnerships in the biotech industry. Kevin's commitment to innovation and excellence has positioned him as a thought leader in the life sciences community.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Startup Experience

Kevin Webster

Work Experience

company logo

Chief Science Officer at

Frontier Medicines

June 2019 - Present

company logo

Sr. Vice President Cancer Biology at

Effector Therapeutics, Inc.

June 2014 - June 2019

company logo

Founder and President at

Partners In Innovation

January 2013 - June 2014

company logo

Vice President Oncology at

AstraZeneca

January 2010 - May 2013

company logo

Executive Director Cancer Bioscience at

AstraZeneca

November 2005 - January 2010

company logo

Global Product Director at

AstraZeneca

August 2006 - February 2007

company logo

Director Cancer Bioscience at

AstraZeneca

December 2001 - November 2005

company logo

Associate Director Oncology Drug Discovery at

Bristol Myers Squibb

January 1991 - January 2001

Logos provided by Logo.dev

Kevin Webster

Education

Yale University, Phd

January 1986 - January 1991

State University of New York- Stony Brook, Bachelor Of Science (B.S.)

January 1982 - January 1986

Frequently Asked Questions about Kevin Webster

What is Kevin Webster email address?

Kevin Webster's primary email address is ********@frontiermeds.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kevin Webster work for?

Kevin Webster is a Chief Science Officer at Frontier Medicines, a company specializing in Commercial physical research.

Where Kevin Webster graduated from?

Kevin Webster holds a degree in Molecular Biophysics And Biochemistry from Yale University.

How can I directly contact Kevin Webster?

To contact Kevin Webster directly, you can use the email address ********@frontiermeds.com. Complete contact information is available upon registration with Muraena.

Who is Kevin Webster?

Kevin Webster is a highly accomplished Chief Scientific Officer at Frontier Medicines, where he leads innovative research in the biopharmaceutical sector, particularly focused on cancer treatment. With a robust academic foundation, including a PhD from Yale University in Molecular Biophysics and Biochemistry, he has dedicated over three decades to advancing drug discovery and development. His extensive experience spans various leadership roles across notable companies like AstraZeneca and Bristol Myers Squibb, where he has significantly contributed to oncology research. Kevin's expertise encompasses a wide range of scientific disciplines, including biochemistry, bioinformatics, and translational medicine. He is passionate about leveraging cutting-edge technologies to create breakthrough therapies that can transform patient outcomes. Beyond his technical acumen, he is recognized for his strategic vision and ability to foster collaborative partnerships in the biotech industry. Kevin's commitment to innovation and excellence has positioned him as a thought leader in the life sciences community.

Kevin`s contact details

mail

********@frontiermeds.com

***************@astrazeneca.com

********@effector.com

Colleagues

avatar
Norbert Schuehler

VP, Information Technology

avatar
Snahel Patel

Vice President, Head of Chemistry

avatar
Sylvia

Chief Of Staff

avatar
Roberto Zoncu

Co-director, Molecular Therapeutics Initiative

Doug Burdette

Vice President of DMPK

Daniel Erlanson

Chief Innovation Officer

avatar
Daniel Nomura

Co-Founder

avatar
Tina Gullotta

Vice President Finance

avatar
Johannes Hermann

Chief Technology Officer

avatar
Victoria Fort

Senior Vice President, Strategy and Corporate Affairs

View Contact details (it's free)
Request Profile Removal